Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T14:20:23.830Z.
Calculation as of: 2026-10-06T14:20:23.830Z.
Quote observation: 2026-10-06T14:20:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6c856baf2af26ca9326fa79b8c43a58fbb1378fdf70f4049426595b89831cd0b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$1.83B
Price/OCF Ratio
22.01
TTM Avg
28.20
3Y Avg
39.35
5Y Avg
38.63
Market Cap
$1.83B
Price/OCF Ratio
10.42
TTM Avg
11.46
3Y Avg
20.12
5Y Avg
20.88
Market Cap
$1.75B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Price/OCF Ratio
N/A
TTM Avg
11.30
3Y Avg
11.30
5Y Avg
11.30
Market Cap
$1.85B
Price/OCF Ratio
N/A
TTM Avg
35.45
3Y Avg
35.45
5Y Avg
35.45
Market Cap
$1.71B
Price/OCF Ratio
8.32
TTM Avg
22.76
3Y Avg
36.91
5Y Avg
32.83
Market Cap
$1.89B
Price/OCF Ratio
111.77
TTM Avg
74.69
3Y Avg
89.69
5Y Avg
89.69
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Absci Corporation (ABSI) | $1.80B | N/A | N/A | N/A | N/A |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.83B | 22.01 | 28.20 | 39.35 | 38.63 |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 10.42 | 11.46 | 20.12 | 20.88 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.75B | N/A | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.74B | N/A | 11.30 | 11.30 | 11.30 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.85B | N/A | 35.45 | 35.45 | 35.45 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 5.42 | 9.21 | 10.96 | 12.42 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.71B | 8.32 | 22.76 | 36.91 | 32.83 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 111.77 | 74.69 | 89.69 | 89.69 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.94B | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
